Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
NervGen Pharma Corp
V.NGEN
Alternate Symbol(s):
NGENF
Healthcare
Biotechnology
NervGen Pharma Corp. is a clinical-stage biotech company. The Company is engaged in discovery, development and commercialization of pharmaceutical products for the treatment of nervous system damage due to injury or disease. The Company is advancing its lead compound, NVG-291, for the treatment of spinal cord injury (SCI), Alzheimer’s disease (AD) and multiple sclerosis (MS). Its NVG-291 is a...
therapeutic peptide, which is a mimetic of the intracellular domain of protein tyrosine phosphatase, a cell surface receptor known to interact with chondroitin sulfate proteoglycans (CSPGs) and to be involved in the regulation of neuroplasticity and central nervous system repair. It has also initiated preclinical evaluation of a new development candidate, NVG-300, in models of ischemic stroke, amyotrophic lateral sclerosis (ALS) and spinal cord injury. The Company's wholly owned subsidiaries include NervGen US Inc. and NervGen Australia Pty Ltd.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:NGEN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
Next
•••
Jonathon Brown
X
Post by
Jonathon Brown
on Apr 17, 2025 9:08am
Buzz on the Bullboards: Energy, cannabis, and biotech shine on the TSX
The developments in Thermal Energy, Tilray, and Oncolytics Biotech highlight the dynamic nature of the stock market and its opportunities.
read article.
(14)
•••
wallpaper2
X
Comment by
wallpaper2
on Apr 10, 2025 12:27am
RE:RE:RE:Listen to Chen Lin, it is near the end.
Chen Lin is a paid newsletter writer. Ceo.ca board appears to be flooded by Sam Brown employees continually pumping the stock.
(14)
•••
wallpaper2
X
Comment by
wallpaper2
on Apr 10, 2025 12:22am
RE:46,000 a month
Trying to manipulate the share price. Total greed. All they have to do is wait for results and the stock will find its proper level. They want to pump it higher so they can bail and fill their pockets
...more
(0)
•••
PressRelease
X
Post by
PressRelease
on Apr 09, 2025 5:54pm
New Press Release - NervGen Provides Quarterly "At-The-Market" Equity Program Update
Vancouver, British Columbia--(Newsfile Corp. - April 9, 2025) - NervGen Pharma Corp.(TSXV: NGEN) (OTCQB: NGENF) ("NervGen" or the "Company"), a clinical-stage biotech company dedicated to developing neurorestorative therapeutics, today provided a quarterly update with respect to the Company's...
read article.
(1)
•••
rdgeo44
X
Post by
rdgeo44
on Apr 08, 2025 10:34am
46,000 a month
This is unbelievable and a slap in the face for all their loyal investors. I invested in NGEN hoping they were an honest company with good iuntentions. Of course I expected to make some money too but
...more
(14)
•••
wallpaper2
X
Post by
wallpaper2
on Apr 07, 2025 10:18am
SP manipulation?
Company recently hired "Sam Brown IR Co." at $46,000.00 PER MONTH to try and promote the share price. Rose approx. .60 cents on NO news, then news came out and it is retracing back where it
...more
(0)
•••
seoorb
X
Post by
seoorb
on Apr 03, 2025 9:15am
NervGen Pharma Corp. – Pioneering Treatments for Nervous Sys
NervGen Pharma Corp. is a clinical-stage biotech company focused on developing groundbreaking therapies for nervous system damage caused by injury or disease. With its lead compound, NVG-291, the
...more
(35)
•••
LowMoor
X
Comment by
LowMoor
on Apr 03, 2025 9:04am
RE:RE:Listen to Chen Lin, it is near the end.
More information on the CEO.Ca board.
(0)
•••
seoorb
X
Comment by
seoorb
on Apr 03, 2025 8:35am
RE:Listen to Chen Lin, it is near the end.
Top Family Business
(35)
•••
LowMoor
X
Post by
LowMoor
on Apr 03, 2025 8:31am
Listen to Chen Lin, it is near the end.
https://taylorjay.substack.com/p/chen-lin-on-gold-silver-copper-cerro?r=1gnrk3&utm_medium=ios&utm_campaign=audio-player
(35)
•••
LowMoor
X
Comment by
LowMoor
on Apr 03, 2025 7:37am
RE:RE:Stock options
$100 a share if NVG-291 is successful. Total moon shot here. Only a few months away, don't wait. Buy.
(6)
•••
Nosleep
X
Comment by
Nosleep
on Jan 13, 2025 4:36pm
RE:Stock options
3.08 today 6 months later, 72 percent gain, and now also cash in the coffers when they exercise the options. So much for your "another very telling sign" only telling sign here is that you
...more
(6)
•••
Nosleep
X
Comment by
Nosleep
on Jul 11, 2024 8:34pm
RE:RE:Stock options
who cares, you either own it and win with them, or lose with them. Stock is do or die, under .50 cents if drug shows no results, so the options are worthless anyways at that point. If the drug works
...more
(14)
•••
wallpaper2
X
Comment by
wallpaper2
on Jul 10, 2024 10:03am
RE:Stock options
VERY TACKY !! Gutless move by weak gutless Board.
(44)
•••
greenland
X
Post by
greenland
on Jun 26, 2024 8:53pm
2nd Annual Spinal Cord Injury Investor Symposium ("2nd SCIIS
NervGen Pharma to Present at the 2nd Annual Spinal Cord Injury Investor Symposium V.NGEN | 6 days ago Vancouver, British Columbia--(Newsfile
...more
(403)
•••
deepoil0808
X
Post by
deepoil0808
on Jun 07, 2024 4:05pm
Stock options
The issuance of stock options does not inspire confidence as these options were given away at cost, with no premium in them. I would have issued stock options (sat triple the amount or 3 million
...more
Prev
1
2
3
4
5
6
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
CONTENT CREATORS: Learn How to Become a Stockhouse Contributor
Tribe Property Achieves Record Revenue of $8.4 million and First Positive Adjusted EBITDA Quarter